Bcl-2 expression was downregulated remarkably in Carvacrol receiving animals relative to those with the untreated breast cancer (***P ≤ 0.001 vs. normal) where Bcl-2 was notably up-regulated. The gene discussed is BCL2; the disease is breast carcinoma.